Drug Profile
Research programme: sodium channel modulators - Biotron
Alternative Names: Hypoxion projectLatest Information Update: 04 Feb 2011
Price :
$50
*
At a glance
- Originator Biotron
- Class
- Mechanism of Action Sodium channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Myocardial infarction; Stroke
Most Recent Events
- 04 Feb 2011 No development reported for Myocardial infarction in Australia (unspecified route)
- 04 Feb 2011 No development reported for Stroke in Australia (unspecified route)
- 27 Jun 2007 Early research in Myocardial infarction in Australia (unspecified route)